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Abstract
Fluoro-Deoxy-Glucose Positron Emission Tomography/Computerized Tomography scan is a very
useful method in the diagnosis and follow-up of gastrointestinal malignancies, although it may cause
confusion in differential diagnosis.
We present a 48-year-old man admitted with a right lower quadrant mass. Upon an unyielding
colonoscopy due to inability to pass beyond the hepatic flexure, a Fluoro-Deoxy-Glucose Positron
Emission Tomography/Computerized Tomography strongly suggested a right colonic or cecal
malignancy. Eventual laparatomy revealed a periappendiceal plastron due to appendicitis that was
subsequently proven histological diagnosis.
Although Fluoro-Deoxy-Glucose Positron Emission Tomography/Computerized Tomography is a
reliable diagnostic tool for colonic malignancies, it can misdiagnose such masses due to inflammatory
process around the cecum.
Introduction
Positron emission tomography (PET), using 18F-fluoro-2-
deoxy-d-glucose (FDG) as a tracer, is preferentially taken
up by most malignant neoplasms with altered glucose
metabolism. In recent years, the fusion of images from
FDG-PET with those of computed tomography (PET/CT)
has aided in the precise localization of increased FDG
uptake sites, which may occur not only in malignant
tumors but also in areas of inflammation and in areas of
physiologic glucose uptake [1]. Lim [2] reported two false
positive PET/CT cases due to chronic inflammation and
suture granuloma.
We aimed to discuss the reliability and applicability of
PET/CT scan when diagnosing colonic malignancies in the
event of intra-abdominal inflammatory processes such as
appendicular plastrons in context with a case.
Case presentation
A 48-year-old Caucasian Turkish male was admitted to ER
with right lower quadrant pain, and accompanying fever,
sweating, constipation and significant weight loss (>10%)
during the last twomonths. Physical examination revealed
normal findings apart from painful right lower quadrant
palpable mass. Routine biochemical analysis and CBC
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were unremarkable. CT examination revealed a 3 × 2 × 2 cm
size conglomerated solid mass with no contrast localiza-
tion. The patient improved and passed flatus after five days
of supportive therapy with IV fluid replacement and
antibiotic therapy and discharged from hospital. It was
considered as a plastroned appendicitis (peri-appendiceal
mass) and periodic ultrasonographic examinations (USG)
were planned for follow-up. However, the USG two weeks
after CT scan, revealed a 5 × 3 cm size irregular contoured,
heterogenous caecal mass that was neighboring with the
urinary bladder. We also proved the increase in size of the
mass by physical examination. This finding has led us to the
primary diagnosis of a colonic malignancy.
In an attempt to rule out a colonic malignancy, an urgent
colonoscopy was performed, which was unyielding due to
inability to pass beyond the hepatic flexure. Therefore, we
performed an FDG PET/CT study to aid in the differential
diagnosis, which showed markedly increased glucose
metabolism in two masses localized in the right lower
quadrant which were 2 cm in diameter (Figure 1, 2).
The high SUV values (early: 10.8, late: 14.7) suggested that
these masses were most likely related with malignant
tissue (Figure 3). Later in several days, the size of mass has
decreased on physical and USG examinations, therefore
we decided to follow-up conservatively. In two months,
themass has reduced to nearly an unpalpable size. Surgical
exploration revealed a peri-appendicular mass consisting
mainly of the omentum at the tip of the appendix. Patient
underwent appendectomy and resection of neighboring
mass. Histopathological examination of specimen con-
firmed the diagnosis of appendicitis. He had an uneventful
postoperative period and discharged from the hospital at
the end of the first week.
Discussion
Combined PET/CT imaging is a non-invasive nuclear
medicine procedure that is gaining increasing application
in oncology as a standard modality in the diagnosis of
occult cancers, restaging and monitoring of therapeutic
efficacy. Metabolic abnormalities detected on PET images
can be precisely localized anatomically by hardware fusion
with the CT images obtained in the same sitting. Tissues
with increased glucose metabolism, such as malignant
lesions, appear as areas of increased activity on PET scans
due to the trapped FDG within the cells. We observed a
Figure 1. Right lower quadrant mass and urinary bladder
activity in coronal section.
Figure 2. Right lower quadrant mass in PET/CT scan in
axial section.
Figure 3. Right lower quadrant mass in axial PET scan.
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strong FDG activity in right lower quadrant of the patient
on PET/CT scans, which was strongly suggesting malignant
tissue, with concomitant clinical signs and symptoms. The
diagnostic use of FDG-PET has been established in colon
cancer [3]. Tahara et al. [4] published data about the use
of 18F-FDG PET in detecting abscesses in 2 patients in
the late 1980s. Since then, numerous case reports have
been published, but data from larger series are rare.
Some inflammatory lesions, especially granulomatous
ones, may be markedly FDG-avid. These include inflam-
matory bowel disease and abscesses [5]. In our case, we did
not encounter an abscess within or around the peri-
appendiceal mass. In addition, the method has been
highly sensitive in imaging patients at a high risk of
infection and of metastatic infectious disease, even when
the results of other diagnostic procedures were normal
[6,7]. However, this situation may cause false positive
malignant tissue interpretations as in our case. However,
Gutman [8] reported a 25% false positivity with FDG PET/
CT uptake in 20 pts (21 foci), which have been proven by
colonoscopy.
Annovazzi et al [9] evaluated the scintigraphic methods
for the diagnosis of diverse intra-abdominal infective/
inflammatory disorders. They have not been able to
find any published matter about the application of
PET/CT on the diagnosis of appendicitis in a peer
review of 20 years evidenced base medicine screening
(1984-2004).
FDG trapped tissues are analyzed semi-quantitatively
using the standard uptake value (SUV), which relates the
activity concentration in a fixed volume of tissue to the
amount of the injected dose and the patient’s body weight.
SUV characteristic of a tissue is as important as the uptake
of the radiopharmaceutical. Gutman et al [8] found a
difference in the mean SUV(max) between false positive
and true-positive colonic FDG foci but not statistically
significant (p = 0.14). They suggested that the presence of a
focal colonic FDG uptake incidental finding on a PET/CT
scan justifies a colonoscopy to detect (pre-) malignant
lesions. In our case, early and late SUV values are 10.8 and
14.7 respectively, which are quite similar of a malignant
tissue. A cut-off SUV value of 3 has been suggested in the
past for the discrimination of benign and malign lesions
but in the gastrointestinal tract variable FDG uptakemeans
that benign lesions can have SUVs of between 5 and 10
[10]. Another study reported dual-point FDG-PET imaging
for differentiating malignant from inflammatory processes
[11]. The authors demonstrated that the SUV significantly
increased in tumors overtime, whereas the SUV of
inflammatory lesions decreased overtime. Imdahl [12]
et al assumed a SUV of 4 as an indicator of possible
malignant lesion which has taken on delayed image
acquisition.
False positivity still seems a diagnostic dilemma of FDG-
PET/CT. False positives may be reduced with the use of
multitracer studies and labelled amino acids instead of the
FDG scan [13]. A different approach using dual time point
imaging was helpful in differentiating malignancy from
inflammation and normal tissue in the head and neck,
particularly when separated by a sufficient time interval of
more than 30 minutes [14]. This method has found
application in head and neck tumours but more studies
are required to investigate its effectiveness in other cancers.
Conclusion
Because FDG is a tracer of glucose metabolism, its
distribution is not limited to malignant tissue. To avoid
misinterpretations, the interpreter must be familiar with
the normal pattern and physiologic variations of FDG
distribution and with clinical data relevant to the patient.
It still seems a diagnostic dilemma to differentiate a peri-
appendicular mass due to an appendicitis from a
malignant mass by means of PET/CT scan. Our case is a
demonstration of a misinterpretation of colonic tumor
due to its high metabolic rate. This clinical condition has
emerged a need for further study on the diagnostic
accuracy of PET/CT scan in the diagnosis of acute
appendicitis and/or peri-appendicular mass.
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